Archive

ShareThis Page
CVS, Aetna draw closer to closing $69B combination | TribLIVE.com
U.S./World

CVS, Aetna draw closer to closing $69B combination

The Associated Press
480434cvsb2f8c2d0cca011e8a36085875bac0b1f
Bloomberg
A CVS store in downtown Los Angeles on Oct. 27, 2017. (Bloomberg photo)

Shares of CVS Health and Aetna are rising with the companies now saying they expect to close their $69 billion tie-up later this week.

The companies say in regulatory filings that they have the final regulatory approval needed and expect to close on or around Wednesday.

CVS Health Corp. had told investors earlier this month that it expected to close the deal for the nation’s third-largest health insurer before Thanksgiving. But its shares slipped last week after the drugstore chain and pharmacy benefit manager said it still lacked approval from two states.

The companies plan to dive deeper into providing care with help from CVS’s nearly 10,000 locations.

Shares of CVS Health advanced nearly 4 percent, while Aetna Inc. climbed more than 2 percent in morning trading.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.